n-(3-pyridylmethyl)adriamycin has been researched along with isoxazoles in 1 studies
| Studies (n-(3-pyridylmethyl)adriamycin) | Trials (n-(3-pyridylmethyl)adriamycin) | Recent Studies (post-2010) (n-(3-pyridylmethyl)adriamycin) | Studies (isoxazoles) | Trials (isoxazoles) | Recent Studies (post-2010) (isoxazoles) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 8,633 | 900 | 3,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Pei, L; Shang, Y; Song, L; Wang, Y; Wu, J; Wu, Y; Xian, W; Yuan, S | 1 |
1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and isoxazoles
| Article | Year |
|---|---|
Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Arginase; Cell Line, Transformed; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Doxorubicin; Electrophoretic Mobility Shift Assay; Interleukin-4; Isoxazoles; Leflunomide; Mice; Microglia; Phosphorylation; PPAR gamma; Signal Transduction; STAT6 Transcription Factor | 2014 |